Atea Pharmaceuticals (AVIR) Treasury Shares (2019 - 2020)

Atea Pharmaceuticals' Treasury Shares history runs 7 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 61.79% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 61.79% YoY), while the FY2025 annual figure was $2.5 million, down 2.26% from the prior year.
• Treasury Shares for Q1 2026 stood at $4.0 million, up from $2.5 million in the prior quarter.
• The five-year high for Treasury Shares was $4.0 million in Q1 2026, with the low at $161750.0 in Q4 2022.
• The 5-year median for Treasury Shares is $2.5 million (2025), against an average of $2.1 million.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares soared 348.2% in 2023, then decreased 10.94% in 2025.
• Atea Pharmaceuticals' Treasury Shares stood at $161750.0 in 2022, then jumped by 348.2% to $724970.0 in 2023, then surged by 248.02% to $2.5 million in 2024, then declined by 2.26% to $2.5 million in 2025, then surged by 61.79% to $4.0 million in 2026.
• Business Quant data shows AVIR's Treasury Shares at $4.0 million in Q1 2026, $2.5 million in Q4 2025, and $2.2 million in Q3 2025.